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Berchowitz et al. establish that transient amyloid-like forms of Rim4, a yeast RNA-binding protein
with a predicted prion domain, translationally repress cyclin CLB3 in meiosis I, thereby ensuring
homologous chromosome segregation. These findings suggest that prion domains might enable
formation of tightly regulated amyloid-like effectors in diverse functional settings.Meiosis yields haploid gametes from
diploid progenitors via two consecutive
rounds of chromosome segregation,
meiosis I and II, following a single S
phase. During meiosis I, homologous
chromosomes segregate, whereas in
meiosis II sister chromatids separate.
Proper meiotic progression requires
translational regulation of specific cyclins,
such as the B-type cyclin, CLB3 in
budding yeast, which is repressed during
meiosis I but translated during meiosis II
(Carlile and Amon, 2008). Aberrant
expression of CLB3 during meiosis I pre-
vents the essential segregation of homol-
ogous chromosomes and triggers prema-
ture sister chromatid separation (Carlile
and Amon, 2008). In this issue of Cell, an
elegant study by Berchowitz et al. (2015)
now establishes that Rim4, a meiosis-
specific RNA-binding protein (RBP) with
a predicted prion domain (Figure 1A) (Al-
berti et al., 2009), forms functional amy-
loid-like conformers that directly repress
CLB3 translation during meiosis I (Ber-
chowitz et al., 2015).
Rim4 is a 713-residue RBP with three
N-terminal RNA-recognitions motifs
(RRMs) and a C-terminal low-complexity
(LC) domain predicted to be predomi-
nantly disordered, which harbors a puta-
tive prion domain (Figure 1A) (Alberti
et al., 2009). Prion domains have an
unusual, low-complexity amino acid
composition comprised of predominantly
uncharged polar amino acids (particularly
glutamine, asparagine, and tyrosine) and
glycine (Alberti et al., 2009; King et al.,
2012). In canonical yeast prion proteins,
the prion domain can switch from anintrinsically disordered conformation to
an infectious cross-b conformation (Al-
berti et al., 2009; King et al., 2012). In the
present study, the authors showed that
in isolation, Rim4 spontaneously assem-
bled into b sheet-rich fibrils, and that
Rim4 fibrillization was RNA-independent
and required the C-terminal LC domain
(Berchowitz et al., 2015). Moreover,
in vivo, the predicted prion domain plus
C-terminal determinants in the LC domain
of Rim4 mediated formation of stable,
SDS-resistant aggregates during pre-
meiotic S phase, which sequestered spe-
cific mRNAs and repressed cyclin CLB3
translation exclusively during meiosis I
(Figure 1B) (Berchowitz et al., 2015).
Indeed, Rim4 variants bearing C-terminal
deletions in the LC domain were unable
to form amyloid-like species or elicit
translational repression in this context
(Berchowitz et al., 2015). Remarkably, at
the onset of meiosis II, increased Ime2 ki-
nase activity triggers rapid degradation of
amyloid-like Rim4 to enable CLB3 trans-
lation and sister chromatid segregation
(Figure 1B) (Berchowitz et al., 2015).
Collectively, these data suggest that the
formation and elimination of amyloid-like
Rim4 is exquisitely timed and tightly
orchestrated to enable a specific transla-
tional repression modality critical for
meiosis I.
Is this mode of regulation specific to
yeast? The answer is probably no. In
fact, humans possess four meiosis-spe-
cific RBPs with predicted prion domains,
DAZ1-4 (King et al., 2012). Moreover, a
related RBP, DAZL (DAZ-like), is crucial
for gametogenesis in mice. In the currentCell 16work, the authors observed that DAZL
forms SDS-resistant aggregates in cells
undergoing meiosis but not in non-
meiotic tissue (Berchowitz et al., 2015).
Thus, similar to Rim4 in yeast, an amy-
loid-like form of DAZL, and perhaps
also DAZ1-4, might play a role in
translational regulation during mamma-
lian gametogenesis.
Rim4 is not the first example of amy-
loid-like species regulating mRNA trans-
lation. However, its repression of CLB3
translation stands in stark contrast to
the translational activation of specific
transcripts sparked by amyloid-like
forms of a neuronal cytoplasmic polya-
denylation element binding protein from
Aplysia californica (ApCPEB) (Shorter
and Lindquist, 2005; Si et al., 2010).
ApCPEB also harbors a prion domain,
which drives assembly of amyloid-like
forms of ApCPEB in response to specific
neurotransmitter cues that stimulate a
translational program that enables syn-
aptic robustness and long-term facilita-
tion (Shorter and Lindquist, 2005; Si
et al., 2010). Like Rim4, the amyloid-like
form of ApCPEB engages specific
RNAs more avidly (Berchowitz et al.,
2015; Shorter and Lindquist, 2005). This
shared ability of amyloid-like forms of
Rim4 and ApCPEB to modulate mRNA
translation suggests that this type of
regulation may be more widespread
than presently appreciated. Remarkably,
1% of human proteins harbor a pre-
dicted prion domain, including at least
50 RBPs (Kim et al., 2013; King et al.,
2012; Li et al., 2013). The pervasiveness
of these domains is cause to ask—is3, October 8, 2015 ª2015 Elsevier Inc. 275
Figure 1. Amyloid-like Forms of Rim4 Repress CLB3 Translation During Meiosis I
(A) Domain architecture of Rim4. Rim4 is divided into an N-terminal RNA-binding domain (red) harboring
three RNA-recognition motifs (RRM1-3) and a C-terminal low-complexity (LC) domain (blue) harboring a
predicted prion domain.
(B) Rim4 expression is induced in premeiotic S phase, and the LC domain of Rim4 (blue) enables assembly
into amyloid-like species. Upon entry into meiosis I, amyloid-like Rim4 represses the translation of cyclin
CLB3 by binding the 50UTR of the CLB3 mRNA (purple). Repression of CLB3 translation enables segre-
gation of homologous chromosomes. Upon transition to meiosis II, Ime2 kinase activity increases and
elicits rapid degradation of amyloid-like Rim4, which relieves inhibition of CLB3 translation thereby
facilitating sister chromatid separation.the formation of amyloid or amyloid-like
states a widely employed mechanism of
cellular regulation underlying transla-
tional control and perhaps a spectrum
of other molecular processes?
It is important to note that amyloid or
amyloid-like conformers are not the only
structures encoded by predicted prion
domains. Indeed, prior to populating
self-templating amyloid-like states, these
intrinsically disordered regions can un-
dergo concentration-dependent liquid
demixing phase transitions. These transi-
tions enable partitioning of various dy-
namic compartments with liquid- or gel-
like properties, including P bodies, stress
granules, and paraspeckles (Hennig et al.,
2015; Li et al., 2013; Patel et al., 2015).
Despite the clear utility of both preamyloid
and amyloid-like conformations encoded
by predicted prion domains, this type of276 Cell 163, October 8, 2015 ª2015 Elseviedomain is a double-edged sword. Indeed,
RBPs with predicted prion domains,
including FUS, TDP-43, hnRNPA1, and
hnRNPA2, have emerged as causative
agents in several fatal neurodegenerative
disorders such as amyotrophic lateral
sclerosis and frontotemporal dementia
(Kim et al., 2013; King et al., 2012; Li
et al., 2013). Here, the predicted prion do-
mains enable RBP misfolding into delete-
rious oligomeric and fibrillar structures
that likely underpin disease, and dis-
ease-linked mutations can accelerate
these misfolding events (Kim et al., 2013;
King et al., 2012; Li et al., 2013; Patel
et al., 2015). In particular, an aberrant
phase transition from liquid- or gel-like
states to more intractable solid phases
mediated by the prion domain is likely a
key pathogenic event (Li et al., 2013; Patel
et al., 2015).r Inc.A critical goal is to accurately under-
stand what primary sequence elements
and auxiliary factors determine whether
predicted prion domains assemble into
functional, beneficial structures or delete-
rious, misfolded conformers that are
pathogenic. Such understanding will
empower the design of therapeutics to
prevent or reverse detrimental RBP mis-
folding trajectories. In this context, a
mechanistic understanding of the devel-
opmentally regulated formation and elim-
ination of amyloid-like Rim4 is likely to be
extremely valuable. For example, the
mechanism by which amyloid-like Rim4
is rapidly degraded during meiosis II re-
mains uncharted. It is not clear how
increased Ime2 kinase activity elicits
this degradation process or whether it
requires protein disaggregases (e.g.,
Hsp110 or Hsp104), proteasomes, or
autophagy. Delineation of this temporally
restricted clearance pathway could
inform effective strategies to eliminate
pathogenic amyloid conformers.REFERENCES
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